drugset / Trial / NCT01384396

A Clinical Study of KW-3357 in Patients With DIC

NCT01384396

Phase 3 Completed 15 enrolled Kyowa Kirin, Inc.
NaSingle-groupOpen-labelTreatment

Summary

To evaluate the efficacy and safety of KW-3357 with concomitant use of heparin using multi-center, non-comparative, open-label method in patients diagnosed as disseminated intravascular coagulation (DIC) by the diagnostic criteria for DIC established by the Japanese Ministry of Health and Welfare.

Timeline

Start
2011-12
Primary completion
2013-04
Completion
2013-04

Drugs

EvaluationDrugModalityDoseRoute
Subject KW-3357 Protein / enzyme biologic Intravenous